
    
      There are 2 cohorts of subjects. Cohort 1 is a single dose study of ARQ-151 0.5% cream
      applied to 25 cm2 of psoriatic plaque(s) in up to 8 psoriasis subjects. Cohort 2 is a
      parallel group, double blind, vehicle controlled study in which ARQ-151 cream 0.5%, ARQ-151
      cream 0.15% or vehicle cream is applied once a day for 28 days to subjects with between 0.5%
      to 5.0% BSA of chronic plaque psoriasis. Including both Cohorts, a total of up to 92 subjects
      will be enrolled at 8 study sites in Canada and the US. Subjects will be adult (â‰¥18 years
      old) males or females with chronic plaque psoriasis.
    
  